FDA extends shelf life of certain IV solutions in short supply
Hospitals may use certain intravenous solutions made by Baxter Healthcare Corp. beyond the labeled expiration date due to the ongoing shortage of IV solutions used in critical care, the Food and Drug Administration announced today. Health care professionals should squeeze the bags before use and not use them if leaks are found, the agency said. The products should continue to be stored as labeled, and should be replaced and properly disposed of as soon as possible if replacement product becomes available during the extension period, FDA said.
Related News Articles
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…